| Year |
Citation |
Score |
| 2019 |
Xiang S, Dauchy RT, Hoffman AE, Pointer D, Frasch T, Blask DE, Hill SM. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer. Journal of Pineal Research. e12586. PMID 31077613 DOI: 10.1111/Jpi.12586 |
0.444 |
|
| 2017 |
Dauchy RT, Pointer DT, Hoffman AE, Wren-Dail MA, Xiang S, Yuan L, Blask DE, Belancio VP, Hill SM. Abstract 3191: Daytime blue-enriched LED light-induced circadian amplification of the nighttime melatonin signal increases sorafenib sensitivity in human hepatocellular carcinoma via enhanced suppression of the Warburg effect Cancer Research. 77: 3191-3191. DOI: 10.1158/1538-7445.Am2017-3191 |
0.323 |
|
| 2015 |
Fu A, Jacobs DI, Hoffman AE, Zheng T, Zhu Y. PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome. Carcinogenesis. 36: 1094-102. PMID 26210741 DOI: 10.1093/Carcin/Bgv105 |
0.497 |
|
| 2015 |
Mao Y, Fu A, Hoffman AE, Jacobs DI, Jin M, Chen K, Zhu Y. The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 3533-9. PMID 25740058 DOI: 10.1007/S13277-014-2989-3 |
0.517 |
|
| 2014 |
Fu A, Hoffman AE, Liu R, Jacobs DI, Zheng T, Zhu Y. Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis. Epigenetics. 9: 730-7. PMID 24503492 DOI: 10.4161/Epi.27996 |
0.345 |
|
| 2014 |
Peters TL, Ferree EJ, Sheng Y, Hoffman AE. Abstract 3403: Circadian fluctuations in “housekeeping” gene expression measured by RNA-seq Cancer Research. 74: 3403-3403. DOI: 10.1158/1538-7445.Am2014-3403 |
0.419 |
|
| 2013 |
Zhu Y, Fu A, Hoffman AE, Figueiro MG, Carskadon MA, Sharkey KM, Rea MS. Advanced sleep schedules affect circadian gene expression in young adults with delayed sleep schedules. Sleep Medicine. 14: 449-55. PMID 23562184 DOI: 10.1016/J.Sleep.2012.12.006 |
0.305 |
|
| 2013 |
Hoffman AE, Demanelis K, Fu A, Zheng T, Zhu Y. Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 736-44. PMID 23396962 DOI: 10.1158/1055-9965.Epi-12-1014 |
0.396 |
|
| 2013 |
Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 327-36. PMID 23334589 DOI: 10.1158/1055-9965.Epi-12-1131-T |
0.344 |
|
| 2013 |
Liu R, Fu A, Hoffman AE, Zheng T, Zhu Y. Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways. Bmc Cell Biology. 14: 1. PMID 23294620 DOI: 10.1186/1471-2121-14-1 |
0.382 |
|
| 2013 |
Mandichak TL, Combs JC, Ferree EJ, Hoffman AE. Abstract 5303: Biomarker development for the evaluation of molecular circadian desynchrony in a single measurement. Cancer Research. 73: 5303-5303. DOI: 10.1158/1538-7445.Am2013-5303 |
0.4 |
|
| 2013 |
Fu A, Hoffman AE, Liu R, Jacobs DI, Zheng T, Zhu Y. Abstract 4580: Targetome profiling, pathway analysis and genetic association study implicate miR-618 in follicular lymphomagenesis. Cancer Research. 73: 4580-4580. DOI: 10.1158/1538-7445.Am2013-4580 |
0.394 |
|
| 2013 |
Combs J, Mandichak T, Ferree E, Hoffman AE. Abstract 1798: The human mammary circadian transcriptome. Cancer Research. 73: 1798-1798. DOI: 10.1158/1538-7445.Am2013-1798 |
0.416 |
|
| 2012 |
Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG, Zhu Y. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Molecular Carcinogenesis. 51: 923-9. PMID 22006848 DOI: 10.1002/Mc.20862 |
0.491 |
|
| 2012 |
Hoffman AE, Demanelis KC, Zheng T, Zhu Y. Abstract 2638: Genetic association analysis of the AMP dependent protein kinase complex and NHL risk Cancer Research. 72: 2638-2638. DOI: 10.1158/1538-7445.Am2012-2638 |
0.457 |
|
| 2012 |
Hoffman AE, Liu R, Zheng T, Fu A, Slack F, Zhu Y. Abstract 1652: Targetome profiling and genetic association analyses implicate miR-202 in follicular lymphomagenesis Cancer Research. 72: 1652-1652. DOI: 10.1158/1538-7445.Am2012-1652 |
0.388 |
|
| 2011 |
Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T, Hansen J. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiology International. 28: 852-61. PMID 22080730 DOI: 10.3109/07420528.2011.618896 |
0.488 |
|
| 2011 |
Leaderer D, Hoffman AE, Zheng T, Fu A, Weidhaas J, Paranjape T, Zhu Y. Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. International Journal of Molecular Epidemiology and Genetics. 2: 9-18. PMID 21552306 |
0.442 |
|
| 2011 |
Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, et al. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. The Lancet. Oncology. 12: 377-86. PMID 21435948 DOI: 10.1016/S1470-2045(11)70044-4 |
0.457 |
|
| 2011 |
Kim SJ, Kelly WK, Fu A, Haines K, Hoffman A, Zheng T, Zhu Y. Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer. Cancer Letters. 302: 47-53. PMID 21237555 DOI: 10.1016/J.Canlet.2010.12.010 |
0.39 |
|
| 2011 |
Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE, Mu L, Risch H, Yu H. Let-7a regulation of insulin-like growth factors in breast cancer. Breast Cancer Research and Treatment. 126: 687-94. PMID 20848182 DOI: 10.1007/S10549-010-1168-5 |
0.4 |
|
| 2011 |
Zhu Y, Stevens R, Hoffman A, Tjonneland A, Vogel U, Zheng T, Hansen J. Abstract 4653: Can shift-work shift epigenetic patterns? – Genome-wide methylation profiling and cancer pathway analysis Cancer Research. 71: 4653-4653. DOI: 10.1158/1538-7445.Am2011-4653 |
0.452 |
|
| 2011 |
Zhu Y, Stevens R, Hoffman A, Tjonneland A, Vogal U, Zheng T, Hansen J. Genome-wide methylation changes in night working women in Denmark: same altered promoter methylation of CLOCK and CRY2 as in breast cancer cases Occupational and Environmental Medicine. 68: A18-A18. DOI: 10.1136/Oemed-2011-100382.56 |
0.484 |
|
| 2010 |
Hoffman AE, Zheng T, Ba Y, Stevens RG, Yi CH, Leaderer D, Zhu Y. Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways. Bmc Cancer. 10: 110. PMID 20334671 DOI: 10.1186/1471-2407-10-110 |
0.388 |
|
| 2010 |
Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prevention Research (Philadelphia, Pa.). 3: 539-48. PMID 20233903 DOI: 10.1158/1940-6207.Capr-09-0127 |
0.515 |
|
| 2010 |
Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Research. 70: 1459-68. PMID 20124474 DOI: 10.1158/0008-5472.Can-09-3798 |
0.537 |
|
| 2010 |
Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Research and Treatment. 120: 663-9. PMID 19649706 DOI: 10.1007/S10549-009-0484-0 |
0.506 |
|
| 2010 |
Paranjape TS, Heneghan H, Pelletier C, Hoffman A, Kerin MJ, Harris L, Zhu Y, Miller N, Zelterman D, Tuck D, Slack F, Weidhaas J. Abstract 3029: A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer Cancer Research. 70: 3029-3029. DOI: 10.1158/1538-7445.Am10-3029 |
0.393 |
|
| 2009 |
Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Research. 69: 9315-22. PMID 19934327 DOI: 10.1158/0008-5472.Can-09-0648 |
0.416 |
|
| 2009 |
Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Research. 69: 5970-7. PMID 19567675 DOI: 10.1158/0008-5472.Can-09-0236 |
0.449 |
|
| 2009 |
Yi CH, Zheng T, Leaderer D, Hoffman A, Zhu Y. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis. Cancer Letters. 284: 149-56. PMID 19457610 DOI: 10.1016/J.Canlet.2009.04.017 |
0.462 |
|
| 2009 |
Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Research. 69: 3605-13. PMID 19318546 DOI: 10.1158/0008-5472.Can-08-4572 |
0.481 |
|
| 2008 |
Hoffman AE, Zheng T, Ba Y, Zhu Y. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Molecular Cancer Research : McR. 6: 1461-8. PMID 18819933 DOI: 10.1158/1541-7786.Mcr-07-2094 |
0.46 |
|
| 2008 |
Zhu Y, Hoffman A, Wu X, Zhang H, Zhang Y, Leaderer D, Zheng T. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Mutation Research. 639: 80-8. PMID 18191955 DOI: 10.1016/J.Mrfmmm.2007.11.005 |
0.331 |
|
| 2008 |
Zhu Y, Stevens RG, Leaderer D, Hoffman A, Holford T, Zhang Y, Brown HN, Zheng T. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Research and Treatment. 107: 421-5. PMID 17453337 DOI: 10.1007/S10549-007-9565-0 |
0.499 |
|
| 2007 |
Zhu Y, Leaderer D, Guss C, Brown HN, Zhang Y, Boyle P, Stevens RG, Hoffman A, Qin Q, Han X, Zheng T. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. International Journal of Cancer. Journal International Du Cancer. 120: 432-5. PMID 17096334 DOI: 10.1002/Ijc.22321 |
0.438 |
|
| Show low-probability matches. |